Universitaetsmedizin Mainz

Mainz 55131

1 studies enrolling now · 12 studies all time

What they study most

Advanced Cholangiocarcinoma, Atopic Dermatitis, Cerebral Stroke, Esophageal Adenocarcinoma, Esophageal Squamous Cell Cancer, FGFR2 Gene Rearrangements, Hidradenitis Suppurativa, Idiopathic Intracranial Hypertension, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Lupus Erythematosus, Systemic, Pancreatic Cancer, Peripheral T Cell Lymphoma

Studies at this site

• Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System — Recruiting now
• A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors — Running, not enrolling
• CERENOVUS Neurothrombectomy Devices Registry — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed
• Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides — Completed
• A Trial to Determine the Efficacy and Safety of Presendin in IIH — Stopped early
• A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa — Stopped early